Related Experiment Videos
Quantitative nonradioactive CAT assays using fluorescent BODIPY 1-deoxychloramphenicol substrates
C K Lefevre1, V L Singer, H C Kang
1Molecular Probes, Inc., Eugene, OR, USA.
Biotechniques
|September 1, 1995
Summary
New fluorescent BODIPY 1-deoxychloramphenicol substrates simplify chloramphenicol acetyltransferase (CAT) activity assays. These substrates offer improved quantitation and a wider linear detection range for CAT enzyme activity.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Chloramphenicol acetyltransferase (CAT) is a crucial enzyme in molecular biology.
- Current methods for quantifying CAT activity can be complex due to multiple acetylation products.
- Existing assays may have limitations in linear detection range and quantitation accuracy.
Purpose of the Study:
- To develop novel fluorescent substrates for improved CAT activity assays.
- To enhance the accuracy and efficiency of CAT enzyme quantitation.
- To extend the linear detection range of CAT activity measurements.
Main Methods:
- Synthesis of fluorescent BODIPY 1-deoxychloramphenicol substrates.
- Assay development utilizing the novel substrates for CAT activity detection.
- Comparison of assay performance with traditional methods using [14C]chloramphenicol.
Main Results:
- The new substrates simplify CAT activity quantitation by producing a single product.
- Assays demonstrate an extended linear detection range (≥3.6 orders of magnitude).
- Sensitivity is comparable to radioactive methods, with results available in hours.
Conclusions:
- BODIPY 1-deoxychloramphenicol substrates offer a streamlined, nonradioactive method for CAT assays.
- These substrates improve quantitation and expand the linear range of CAT activity detection.
- The developed substrates represent a valuable advancement over existing CAT assay methodologies.